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Optimization of the fermentation process using the gene amplified variant of Amycolatopsis 
mediterranei, NCH, in the fermentation medium F2 was carried out by the application of fed-batch 
regime. The addition of 12% glucose alone at day 4 or simultaneously with 0.1% yeast extract at day 2 
led to an increase in the yield of rifamycin B by 46% and 57%, respectively. The application of fed-batch 
regime together with replacing (NH4)2SO4 with the better yielding inorganic nitrogen sources NH4NO3 or 
KNO3 (F2m1 and F2m2 media, respectively) increased the production of rifamycin B. The use of F2m1 
medium alone or with an additional 12% glucose added at day 4 increased the yield by 53% and 120%, 
respectively. However, further addition of 0.1% yeast extract led to an increase in the yield by only 63%. 
The addition of 3% soytone or 0.05% NH4NO3 to F2m1 at day 3 increased the yield by 72% and 61%, 
respectively, compared to productivity in F2 medium. The use of F2m2 medium increased the yield by 
50%. The addition of 12% glucose at day 4 or of 0.1% yeast extract at day 2 to F2m2 medium led to an 
increase in the yield by 119 and 55%, respectively, compared to F2 medium. However, when both 12% 
glucose and 0.1% yeast extract were added at similar scheduled times only 64% increase in the yield 
occurred. By applying the three most effective optimization regimes determined using variant NCH with 
F2m2 medium on a standard rifamycin B producing strain, Nocardia mediterranei ATCC 21789, a similar 
pattern of increase in the antibiotic yield was observed. Thus, the use of F2m2 instead of F2 medium 
either alone or with an additional 12% glucose added at day 4 increased the yield by 36 and 75%, 
respectively, whereas the addition of 0.1% yeast extract to F2 medium increased the yield by 15%. In 
conclusion, the application of fed-batch technique with the optimum modifications of the medium 
constituents increased rifamycin B production by variant NCH to a maximum of 17.17 g/l compared to a 
yield of 5.3 g/l by the tested standard strain under the same conditions. The increase in rifamycin B 
production using the standard strain confirms the usefulness of the tested medium modifications in the 
improvement of rifamycin B production and its possible application in fermentations using other 
rifamycin B producer strains and also shows the superiority of variant NCH as a producer, when 
compared to the standard strain. 
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One of the purposes of fed-batching is to make the 
substrate(s) available to the microorganism at an 
optimum concentration for a longer period of time or at 
specified times of the process. In the fed-batch mode, 
gradual addition of concentrated additives, e.g. nutrients, 
takes   place.   Fed-batch   cultures   can   be    used    for 
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fermentation processes in which the products are either 
growth associated or non-growth associated (Trevan et 
al., 1988).In the course of the development of the 
fermentation process for production of rifamycin B, fed-
batch fermentations have been developed in order to 
extend the production phase, where sources of sugar, 
organic and inorganic nitrogen were fed batchwise or 
continuously (Ghisalba et al., 1984; Lancini and Cavalleri, 
1997).  




Our previous attempts to improve rifamycin B 
productivity by development of an amplified variant NCH 
of A. mediterranei by application of gene amplification 
technique and by modification of the fermentation 
medium resulted in a 10.4-fold increase in productivity 
from 1.15 to 11.99 g/l (El-Tayeb et al., 2004a, b). In the 
present work, we tried to optimize the fermentation 
process by replacing (NH4)2SO4 with NH4NO3 or KNO3 
and fed-batching different concentrations of carbon, 
organic and inorganic nitrogen sources and finally 
integration of the optimum addition regimes. To test the 
usefulness of the medium modifications in the 
improvement of rifamycin B production and its possible 
application in fermentations using other rifamycin B 
producer strains, we also applied the most effective 
optimization regimes determined using variant NCH on a 
standard rifamycin B producing strain. 
    
 
MATERIALS AND METHODS 
 
Bacterial strains  
 
The lyophilized standard strain Nocardia mediterranei ATCC 21789 
was propagated on International Streptomyces Project (ISP) or 
Bennett’s agar media. The amplified variant NCH of A. 
mediterranei–RCP 1001, previously obtained as described by El-
Tayeb et al. (2004a), and the standard strain were maintained on 
Q/2 agar slants and stored at 4°C to be used within 27 days. For 
long-term storage, the surface growth on Q/2 agar slants was 





Chemicals used throughout this work were of laboratory reagent 
grade, unless otherwise indicated. Glucose, KNO3, NH4NO3 and 
NaNO2 were the products of ADWIC, Egypt. Sodium diethyl 
barbiturate (SDB) was the product of Grindstedvaerket A/S, 
Denmark. Potassium sodium tartarate tetrahydrate, 3, 
5_dinitrosalicylic acid, CaCO3, MgSO4.7H2O, KH2PO4, (NH4)2SO4 
and NaOH were the products of E. Merck, Darmstadt, Germany. 





Yeast extract, malt extract, beef extract, tryptone, soytone, skim 
milk, bacto agar and ISP medium were the products of Difco 
Laboratories, Detroit, U.S.A. Oat flakes was obtained from 
commercial suppliers.  
Media used for propagation, selection and maintenance as well as 
the vegetative medium V2 and the fermentation medium F2 were 
those previously reported by El-Tayeb et al. (2004a,b). The ISP 
medium was reconstituted and sterilized according to the indicated 
manufacturer instructions.  
The modified fermentation medium F2m1 is composed of: 
glucose, 120.0 g; soytone, 30.0 g; NH4NO3, 1.0 g; KH2PO4, 1.0 g; 
CaCO3, 8.5 g; MgSO4.7H2O, 0.8 g;  sodium diethyl barbiturate, 1.0 g 
and distilled water to 1000.0 ml. The pH was adjusted to 7.1. The 
modified fermentation medium F2m2 is composed of: glucose, 120 
g; soytone, 35 g; KNO3, 12 g; KH2PO4, 1.0 g; CaCO3, 8.5g;  
MgSO4.7H2O, 0.8 g; sodium diethyl barbiturate, 1.0 g and distilled 







The methods used for maintenance, propagation, selection, 
preparation of inoculum and production of rifamycin B in shake 
flasks as well as determination of remaining glucose concentration, 
biomass and assay of rifamycin B were those previously reported 
by El-Tayeb et al. (2004a,b). For fed-batch experiments, aliquots of 
5 ml of glucose and of 0.5 ml of soytone, yeast extract or NH4NO3 
were taken from sterile stock solutions containing suitable 
concentrations,  and added to the fermentation culture at the 





Application of fed-batch technique 
 
Successive additions of 3%, 4% or 5% glucose to an 
initially glucose-free F2 medium at days 0, 2, 4 and 6 
caused a marked reduction in rifamycin B production 
(Figure 1). On the other hand, addition of 12% glucose to 
the F2 medium (initially containing another 12% glucose) 
at day 4 (Figure 2) increased rifamycin B production from 
7.85 to 11.45 g/l (46%). Augmenting this addition with 
addition of 0.1% yeast extract at day 2 (Figure 2) 




Application of fed-batch technique to modified F2 
medium 
 
We have previously determined that both NH4NO3 and 
KNO3 are superior to (NH4)2SO4 as sources of inorganic 
nitrogen in F2 medium and led to an  increase in the yield 
from 7.85  to  11.99 (53%) and 11.76 g/l (50%), 
respectively (El-Tayeb et al., 2004a,b). Thus, F2m1 and 
F2m2 were formulated by replacing 0.6% (NH4)2SO4 in F2 
medium with 0.1% NH4NO3 and 1.2% KNO3, respectively. 
The use of F2m1 medium, instead of F2, either alone or 
with an additional 12% glucose added at day 4 increased 
the yield by 53% and 120%, respectively. However, 
further addition of 0.1% yeast extract led to an increase in 
the yield by only 63% (Figure 3). The batch-wise addition 
of 0.025, 0.05 and 0.075% NH4NO3  to F2m1 medium at 
day 3 increased the yield by 52, 61 and 57%, respectively 
(Figure 3), as compared to the yield in F2 medium, with 
0.05% NH4NO3 producing the highest yield, 12.62 g/l. 
The batch-wise addition of 1, 2 and 3% soytone to F2m1 
medium at day 3 increased the yield by 58, 65 and 72%, 
respectively (Figure 3), as compared to the yield in F2 
medium, with 3% soytone producing the highest yield, 
13.53 g/l.  
The batch-wise addition of 0.1% yeast extract at day 2 
or of 12% glucose at day 4 to F2m2 medium (Figure 4) 
increased rifamycin B production to 12.17 (55%) and 
17.17 g/l (119%), respectively, compared to productivity 
in F2 medium, whereas their combined addition resulted 
in only 64% increase in the yield.  
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(P) control F2 (P) 3% glucose, days 0, 2, 4& 6
(P) 4% glucose, days  0, 2, 4& 6 (P) 5% glucose, days 0, 2, 4& 6
(X) control F2 (X) 3% glucose, days 0, 2, 4& 6
(X) 4% glucose, days 0, 2, 4& 6 (X) 5% glucose, days 0, 2, 4& 6
(pH) control F2 (pH) 3% glucose, days  0, 2, 4& 6
(pH) 4% glucose, days  0, 2, 4& 6 (pH) 5% glucose, days  0, 2, 4& 6
 
 
Figure 1. Effect of replacing 12% glucose in F2 medium with successive additions of 3%, 4% and 5% of glucose at days 




Production of rifamycin B by the standard strain (N. 
mediterranei ATCC 21789) 
 
The colonies of N. mediterranei ATCC 21789 on 
Bennett’s agar plates varied from 1–5 mm in size; from 
yellow to orange in color and were covered with white 
aerial mycelia. Colonies showing nearly the same 
morphological characteristics (orange, rosette, irregular 
edge and 2-3 mm in diameter), as the previously 
described colony  type 1 of the N1 or NCH strain (El-
Tayeb et al., 2004a,b), were selected for rifamycin B 
production.    
Microscopical examination of the culture in the 
vegetative medium (V2) showed Gram–positive short thin 
filaments arranged radially around hollow centers and no 
spores could be detected. Microscopical examination of 
the culture in the fermentation medium (F2) showed 
characteristic fragmentation of the filaments into short 
rods similar to those of strain N1 and variant NCH (El-
Tayeb et al., 2004 a,b).  
The standard strain produced a yield of 3.02 g/ml in F2 
medium (Figure 5). The addition of 0.1% yeast extract at 
day 2 increased rifamycin B production from 3.02 to 3.49 
g/l (16%). The use of F2m2 increased rifamycin B 
production from 3.02 to 4.12 g/l (36%), while addition of 
12 % glucose at day 4 to F2m2 markedly increased 





Our previous attempts to increase rifamycin B production 
using the amplified variant of A. mediterranei  (NCH) by 
modification of the fermentation medium resulted in a 
yield of 11.99 g/l (El-Tayeb et al., 2004a,b). In the present 
work, another approach was carried out by fed-batch 
addition of carbon, inorganic or organic nitrogen sources. 
Our observation and the previous report of Ghisalba et al. 
(1984) showed that a consistent lag time occurred before 
the beginning of the logarithmic growth and of  detectable  
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(P) control F2 (P) glucose, day 4
(P) yeast extract,day 2 (P) glucose, day 4+ yeast extract, day 2
(X) control F2 (X) glucose, day 4
(X) yeast extract, day 2 (X) glucose, day 4+ yeast extract, day 2
(pH) control F2 (pH) glucose,day 4
(pH) yeast extract, day 2 (pH) glucose, day 4+ yeast extract, day 2
 
 
Figure 2. Effect of addition of 12% glucose at day 4 alone or in combination with 0.1% yeast extract at day 2 to F2 medium 
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antibiotic production which may be attributed to the 
osmotic pressure caused by the high concentration of 
glucose and other soluble nutrients present in the 
fermentation medium as reported by Pape and Rehm 
(1985). We thererfore, tried to reduce the initial 
glucose concentration, by the successive additions of 
3, 4 and 5% glucose  at days 0, 2, 4 and 6  to 
glucose-free F2 medium. These additions gave a 
total glucose concentrations equal to or above the 
control (12, 16 and 20%). However, the results 
showed that the lag phase persisted (Figure 1) and 
rifamycin B production was lower than that produced 
in F2 medium. In addition, a high pH was observed 








Figure 3. Effect of addition of 12% glucose at day 4 alone or in 
combination with 0.1% yeast extract at day 2 and of different 
concentrations of NH4NO3 and of soytone to F2m1 medium on 
rifamycin B production by variant NCH. 

































(P) control F2 (P)  control F2m2
(P) glucose+ F2 (P) glucose+ F2m2
(P) yeast extract+ F2 (P) yeast extract + F2m2
(P)  glucose+ yeast extract+ F2m2 (pH)  glucose+ yeast extract+ F2m2
(pH) control F2 (pH)  control F2m2
(pH) glucose+ F2 (pH) glucose+ F2m2
(pH) yeast extract+ F2 (pH) yeast extract+ F2m2
 
 
Figure 4. Effect of single or combined additions of 0.1% yeast extract at day 2 and of 12% glucose at day 4 




This increase in pH may be due to the utilization of 
intermediate organic acids by the microorganism after the 
consumption of the relatively small amounts of glucose 
initially present as well as the appearance of nitrogenous 
materials metabolized from proteins (Lee et al., 1983). 
This observation could suggest that high initial 
concentration of glucose in the fermentation medium is 
required for both growth and production of the antibiotic. 
Based on the reported need for glucose for the 
biosynthesis of the antibiotic during the idiophase (Lee 
and Rho, 1994) and on our observation that the apparent 
rate of glucose consumption increased between day 2 
and 4, we tried the batch-wise addition of 12% glucose at 
day 4 to F2 medium. This led to an increase in the yield 
from 7.85 to 11.45 g/l (46%) along with a sharp increase 
in sugar utilization and a slight decrease in pH (Figure 2). 
Yeast extract contains the B factor that regulates the 
production of the rifamycin B precursor 3-amino-5-
hydroxybenzoic acid which is the starter unit (chain 
initiator) for the assembly of a polyketide in rifamycin 
biosynthesis as reported by Kawaguchi et al. (1984, 
1988). In a previous study, we have shown that the 
addition  of 0.1% yeast extract at day 2 to F2 medium 
increased rifamycin B production by 21% (El-Tayeb et al., 
2004 a). Thus we tried to further increase the yield, by 
augmenting the positive effect of fed-batching 12% 
glucose at day 4 (46%) with addition of 0.1% yeast 
extract at day 2. The yield increased, however, by only  
57%  (Figures 2 and 6). Relatively large amounts of 
nitrogen are necessary to stimulate rifamycin B 
production (Ghisalba et al., 1984). In addition, nitrate 
stimulates rifamycin production by its regulatory effect on 
lipid and rifamycin biosynthetic pathways (Rui_Shen et 
al., 1979). We have previously determined that both 
NH4NO3 and KNO3 are superior to (NH4)2SO4 as sources 
of inorganic nitrogen in F2 medium and led to an  
increase in the yield from 7.85  to  11.99 and 11.76 g/l, 
respectively (El-Tayeb et al., 2004a,b). Thus, F2m1 and 
F2m2 media were formulated by replacing 0.6% 
(NH4)2SO4 in F2 medium with 0.1% NH4NO3 and 1.2% 
KNO3, respectively. Therefore, we tried to further increase 
the yield of rifamycin B by the batch-wise addition of 
0.025, 0.05 and 0.075% NH4NO3 to F2m1 medium 
(Figure 3) at day 3, where the yield increased  by  52,  61  

























































































Figure 5. Effect of addition of 0.1% yeast extract at day 2  to F2 medium and of 12% glucose at day 4 to F2m2 medium on 





























Figure 6. Comparison between rifamycin B production on day 8 by variant NCH in F2, F2m1 and F2m2 media 






Figure 7. Comparison between rifamycin B production on day 8 by 




and 57%, respectively, as compared to the yield in F2 
medium, and by 2, 8, and 5% as compared to that of 
F2m1 medium. These increases are considered only 
minor and thus, the batch-wise addition of inorganic 
nitrogen sources to the modified fermentation media was 
not worthy of further investigation at this stage. 
The addition of organic nitrogen compounds is 
generally recognized to be essential for high yields of 
rifamycin B production by serving either as a precursor or 
stimulant for antibiotic biosynthesis (Gresham and 
Inamine, 1986). The batch-wise addition of 1, 2 and 3% 
soytone to F2m1 medium at day 3 increased the yield by 
58, 65 and 72%, respectively (Figure 3), as compared to 
the yield in F2 medium.  
Furthermore, the batchwise addition of 12% glucose to 
F2m1 medium increased the yield of rifamycin B to 17.3 
g/l (120% compared to F2 medium). Based on the lower 
cost of NH4NO3 and the comparable high yield of NH4NO3 
(F2m1) to that of KNO3 (F2m2), F2m1 medium was 
chosen for further fed-batch mode fermentations using 
the fermentor. 
By the batch-wise addition of 12% glucose or 0.1% 
yeast extract to F2m2 medium, it was possible to increase 
the yield of rifamycin B to 17.17 (119%) and 12.17 g/l 
(55%), respectively, and the addition  of both only 
increased the yield to 12.88 g/l (64%), compared to the 
yield in F2 (Figures 4 and 6). However, the biomass was 
comparable in all these experiments. It was also noted 
that the pH was lower and the remaining glucose was 
higher (day 6-8) when both yeast extract and glucose 
were added to either F2m1 or F2m2 media than those 
observed upon using these media alone or with addition 
of either yeast extract or glucose (data not shown). These 
results suggest that the effect of the combination of yeast 
extract and glucose added to F2m1 or to F2m2  media  is  




on the biosynthesis of rifamycin B and is not related to 
growth of the microorganism. Thus, the stimulation of 
rifamycin B production  obtained by fed-batch addition of 
12% glucose to these media could be due to the 
development of either a more active system for rifamycin 
B production or a less active system for rifamycin B 
inhibition (Krishna et al., 2000) and the better availability 
of glucose during the idiophase (Lee and Rho, 1994). 
This standard strain (N. mediterranei ATCC 21789) 
showed microscopical characteristics on both V2 and F2 
media similar to those observed with strain N1 and 
variant NCH, whereas the morphology of the colonies 
was only slightly different. On Bennett’s agar medium, the 
selected colonies had nearly the same morphological 
characteristics as colony type 1 of strain N1 or variant 
NCH (El-Tayeb et al., 2004a,b). One may suspect that all 
these strains belong to the same morphological group. As 
regards production of rifamycin B, the selected colonies 
produced only 3.02 g/l in F2 medium compared to 7.85 
g/l produced by variant NCH (Figures 5 and 7). 
The use of the most effective medium constituents in 
their optimum concentrations determined from the 
previous optimization experiments using strain N1 and 
variant NCH was tried using this standard strain (Figure 
5). The use of F2m2 medium increased rifamycin B 
production to 4.12 g/l (36%) as compared to 3.02 g/l in F2 
medium. It was observed that the effect of KNO3 on 
biomass, glucose utilization and pH showed the same 
pattern during the time course of fermentation as that 
observed with strain N1 and variant NCH (El-Tayeb et al., 
2004a,b). The addition of 0.1% yeast extract at day 2 to 
F2 medium increased rifamycin B production from 3.02 to 
3.49 g/l (16%).  By further addition of 12% glucose at day 
4 to F2m2 medium, the yield of rifamycin B increased 
from 3.02 to 5.3 g/l (75%). 
In conclusion, among all the tested regimes, the batch-
wise addition of glucose together with modification of the 
fermentation medium, by using F2m2 medium, increased 
rifamycin B production by NCH strain to a maximum of      
17.17 g/l compared to a yield of 5.3 g/l by the standard 
strain under the same conditions (Figure 7). The increase 
in rifamycin B production using the standard strain 
confirms the usefulness of the tested medium 
modification regimes in the improvement of antibiotic 
production and its possible application in fermentations 
using other rifamycin B producer strains and also shows 
the superiority of variant NCH as a producer, when 
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